New research restores psychedelics’ medical respectability
By Eric W. Dolan
Tuesday, September 7th, 2010 -- 3:18 pm
.............
Recently, a study published in the Archives of General Psychiatry found psilocybin, the active substance in 'magic mushrooms,' can safely improve the moods of patients with advanced-stage cancer and anxiety.
..............
In Dr. Grob's study, twelve volunteers, ages 36 to 58, with advanced-stage cancer and anxiety were given a moderate dose of psilocybin and, on a separate occasion, a placebo. The study employed a double-blind procedure, meaning neither the volunteers nor the researchers monitoring them knew whether they'd been given a placebo or psilocybin.
After receiving a dose of psilocybin or a placebo, volunteers were monitored for six hours. They were encouraged to lie in bed, wear eye shades and listen to soft music during the first few hours after ingesting the medication or the placebo. The volunteers were then interviewed after the six-hour session and over the next six months to assess the consequences of the treatment.
The study found a significant improvement of mood and a reduction in symptoms of anxiety up to six months after receiving psilocybin-assisted therapy.
more:
http://www.rawstory.com/rs/2010/09/research-restores-psychedelics-medical-respectability/